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Abstract:  Superparamagnetic  iron  oxide  nanoparticles  are  widely  used  in  biomedical 
applications, yet questions remain regarding the effect of nanoparticle size and coating on 
nanoparticle cytotoxicity. In this study, porcine aortic endothelial cells were exposed to  
5  and  30  nm  diameter  iron  oxide  nanoparticles  coated  with  either  the  polysaccharide, 
dextran,  or  the  polymer  polyethylene  glycol  (PEG).  Nanoparticle  uptake,  cytotoxicity, 
reactive oxygen species (ROS) formation, and cell morphology changes were measured. 
Endothelial  cells  took  up  nanoparticles  of  all  sizes  and  coatings  in  a  dose  dependent 
manner, and intracellular nanoparticles remained clustered in cytoplasmic vacuoles. Bare 
nanoparticles in both sizes induced a more than 6 fold increase in cell death at the highest 
concentration (0.5 mg/mL) and led to significant cell elongation, whereas cell viability and 
morphology remained constant with coated nanoparticles. While bare 30 nm nanoparticles 
induced significant ROS formation, neither 5 nm nanoparticles (bare or coated) nor 30 nm 
coated nanoparticles changed ROS levels. Furthermore, nanoparticles were more toxic at 
lower concentrations when cells were cultured within 3D gels. These results indicate that 
both  dextran  and  PEG  coatings  reduce  nanoparticle  cytotoxicity,  however  different 
mechanisms may be important for different size nanoparticles. 
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1. Introduction 
Superparamagnetic iron oxide nanoparticles  are widely used in biomedical applications such as 
drug delivery [1], magnetic resonance imaging [2], magnetic hyperthermia [3], and cell labeling and 
separation [4]. The nanoparticles can be manipulated using an external magnetic field, yet they do not 
retain their magnetic properties when the magnetic field is removed [5]. Our long-term goal is to use 
iron oxide nanoparticles as drug carriers for atherosclerosis treatment; however, before we develop this 
drug delivery platform, we must determine the endothelial toxicity of the nanoparticles themselves. 
The  endothelium  could  also  be  an  important  drug  delivery  target  for  promoting  or  inhibiting 
angiogenesis in wound healing or cancer, respectively [6]. In addition, when these nanoparticles are 
injected into the bloodstream for imaging studies or drug delivery to other organs, they will first make 
contact with the endothelium before subsequently reaching the targeted tissue. Iron oxide nanoparticle 
interactions with endothelial cells are therefore of particular importance and interest. Bare iron oxide 
nanoparticles are cytotoxic. Cell viability and metabolic activity decrease significantly when cells are 
exposed to high iron oxide nanoparticle concentrations [7–10]. The best developed theory to explain 
nanoparticle-induced  cytotoxicity  is  reactive  oxygen  species  (ROS)  generation.  ROS  are  normally 
formed in vivo at low levels for cell signaling or at higher levels by macrophages and neutrophils 
fighting infection [11]. In these conditions, ROS are quickly neutralized by antioxidant defenses [12]. 
ROS are thought to be induced by iron oxide nanoparticles through a combination of NADPH oxidase 
during endocytotosis, direct formation of free radicals on the nanoparticle surface, and catalysis to 
more  reactive  ROS  forms  via  the  Fenton  reaction  [13].  As  nanoparticle-induced  ROS  rise  with 
increasing nanoparticle concentration, these ROS can cause damage to the cell membrane, DNA, and 
ROS-mediated signal transduction [14]. Nanoparticle-induced ROS have also been shown to alter the 
actin cytoskeleton and cell stiffness [15]. This effect may feed back on itself, since decreased actin 
dynamics induce mitochondrial membrane depolarization and further increase the ROS production 
resulting in cell death [16].  
Iron oxide nanoparticles are generally coated to reduce aggregation and cytotoxicity [17]. Dextran 
(C6H10O5), a branched polysaccharide, is commonly used to coat nanoparticles. In solution, dextran 
interacts with the metal nanoparticle surface to form 20 to 150 nm coated aggregates [18]. Dextran 
coated iron oxide nanoparticles have been used for many purposes, including as MRI contrast agents, 
to investigate nanoparticle accumulation and cellular uptake in malignant neoplasms in vivo, and to 
transform  nanoparticles  into  active,  targeted  probes  [19–21].  Polyethylene  glycol  (PEG)  is  a 
hydrophilic  polymer  that  is  stable,  biocompatible,  and  used  in  many  drug  and  gene  delivery 
applications [22]. PEG coatings have been used to reduce phagocytic capture of nanoparticles by the 
immune  system,  which  can  extend  nanoparticle  circulation  time  and  subsequent  accumulation  in 
targeted tissue [23]. Int. J. Mol. Sci. 2012, 13  5556 
 
 
Nanoparticle  size  plays  an  important  role  in  nanoparticle  cellular  uptake.  In  vivo  experiments 
showed  that  as  the  diameter  of  superparamagnetic  magnetite-dextran  nanoparticles  increased,  
the  liver  uptake  also  increased  [24].  Similarly,  larger  nanoparticles  improved  cell  uptake  of  
carboxydextran-coated iron oxide nanoparticles, which enhanced cell tagging and lipofection-based 
methods  [25].  Nanoparticle  size,  in  addition  to  structure  and  surface  coating,  affects  cytotoxicity. 
However, so far there are inconsistent conclusions as to whether large or small nanoparticles induce 
higher nanoparticle cytotoxicity. For nickel ferrite nanoparticles tested in neuroblastoma cells, larger 
nanoparticles (150 ±  50 nm diameter) induced higher cytotoxicity than smaller particles (10 ±  3 nm 
diameter) [26]. Similarly, silver nanoparticles (<100 nm) were less toxic to Drosophila eggs than those 
greater than 100 nm in size [27]. In other studies, smaller silver nanoparticles (10 nm) induced a 
greater apoptotic effect in osteoblasts than larger nanoparticles (50 and 100 nm), and 21 nm silica 
nanoparticles  were  less  toxic  than  48  nm  nanoparticles  in  myocardial  cells  [28].  Therefore  the 
relationship between nanoparticle size and cell toxicity remains an important area of study. 
While iron oxide nanoparticles and their cytotoxic effects are widely studied in vitro and in vivo, 
much remains to be understood regarding the effect of both nanoparticle size and coating on toxicity 
mechanisms.In this study, we coated 5 and 30 nm nanoparticles with dextran and PEG and investigated 
cytotoxicity,  ROS  formation,  and  actin  cytoskeleton  disruption  in  endothelial  cells.  We  further 
compared cytotoxicity in 2D cell culture to cells suspended in a 3D hydrogel. Our data show that while 
iron oxide nanoparticle coatings decrease cytotoxicity, the mechanism may vary for 5 and 30 nm 
nanoparticles. In addition, nanoparticles are toxic at lower concentrations in 3D culture. This study 
clarifies how nanoparticle size and coating affect cytotoxicity in endothelial cells and will contribute to 
enhanced nanoparticle design for biomedical applications.  
2. Results and Discussion 
2.1. Nanoparticle Coating  
The objective of this study was to determine how different nanoparticle coatings affect cytotoxicity 
mechanisms for two different nanoparticle sizes. We first verified that nanoparticles could be coated 
with  both  dextran  and  PEG.  After  1  h  of  coating,  a  thin  dextran  or  PEG  layer  formed  on  the 
nanoparticle surface for both 5 nm and 30 nm nanoparticles (Figure 1). For 5 nm particles, the average 
layer thickness was around 2 nm, whereas for 30 nm particles, the coating layer thickness was slightly 
larger  at  around  5  nm.  Coating  layer  thickness  increased  with  longer  coating  times.  Nanoparticle 
coating stability was confirmed for up to three months of storage at 4 ° C by TEM. All nanoparticles in 
these experiments were used within one month of coating, and no changes in coated nanoparticle 
cellular effects were observed over this storage time. 
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Figure 1. 5 and 30 nm nanoparticles were coated with dextran and polymer polyethylene 
glycol  (PEG).  Nanoparticle  samples  were  sonicated  for  1  h  with  either  dextran  or  
m-PEG-silane and imaged by TEM. 
 
2.2. Cell Uptake of Iron Oxide Nanoparticles 
Cell nanoparticle uptake was measured qualitatively by TEM and quantitatively by iron absorbance. 
After 3 h, bare and coated nanoparticles were taken into cells and clustered in cytoplasmic vacuoles 
(Figure 2). No nanoparticles were observed in cell nuclei. Intracellular iron concentration increased in 
a nanoparticle dose-dependent manner for both 5 and 30 nm nanoparticles. For 5 nm nanoparticles, 
dextran coated nanoparticles showed the highest cellular uptake for each concentration. At 0.5 mg/mL, 
cells incubated with dextran coated nanoparticles had more than 50% more intracellular iron than cells 
incubated with bare and PEG coated nanoparticles. However, for 30 nm nanoparticles, cells took up 
more bare nanoparticles than coated ones. Cells incubated with 0.5 mg/mL bare nanoparticles had 20.2% 
and 26.6% more intracellular iron than cells incubated with dextran or PEG coated nanoparticles. 
2.3. Cytotoxicity 
Both 5 nm and 30 nm bare nanoparticles decreased cell viability as measured by a Live/Dead assay. 
Significant cell death occurred when cells were exposed to 0.5 mg/mL bare nanoparticles of either size, 
with a more than six fold increase in dead cells compared to control cells that were not exposed to 
nanoparticles (Figure 3). However, cell viability remained the same at all nanoparticle concentrations 
for nanoparticles coated with dextran and PEG. Thus nanoparticle coating decreased cytotoxicity, but 
nanoparticle size did not have an effect. 
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Figure 2. Iron oxide nanoparticles were taken into cells after 3 h incubation. (A) Porcine 
aortic endothelial cells  (PAEC) were incubated with  0.1 mg/mL bare,  dextran or PEG 
coated iron oxide nanoparticles. Large nanoparticle aggregation was observed in vesicles in 
the  cytoplasm;  (B)  Intracellular  iron  increased  with  nanoparticle  concentration,  as 
measured  by  iron  absorbance.  *  p  <  0.01  compared  to  0.1  mg/mL  for  same  coating 
condition, # p < 0.05 compared to 0.1 mg/mL for same coating condition. 
 
Figure  3.  Dextran  and  PEG  coating  reduced  iron  oxide  nanoparticle  cytotoxicity,  as 
measured by a Live/Dead assay. PAEC were incubated with 0, 0.1, 0.25 and 0.5 mg/mL of 
5 and 30 nm bare and coated nanoparticles for 24 h. (A) Selected fluorescent images in 
which green = live cells and red = dead cells; and (B) Quantification of dead cell number 
by Image J. * p < 0.01, # p < 0.05. 
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2.4. ROS Formation 
Cells  loaded  with  30  nm  bare  nanoparticles  showed  the  highest  ROS  formation  after  3  h  of 
nanoparticle exposure for all concentrations. At all nanoparticle concentrations, there was minimal 
ROS formation with 5 nm nanoparticles. However, dextran coated 5 nm nanoparticles showed the 
most ROS formation at 0.5 mg/mL, with 23.1% more than cells with no nanoparticles. For 30 nm bare 
nanoparticles,  ROS  fluorescence  intensity  increased  by  56.5%  for  0.5  mg/mL  nanoparticles  as 
compared to cells without any nanoparticles. Dextran coating decreased ROS fluorescent intensity by 
35.2% and PEG coating decreased ROS fluorescent intensity by 62.6% at 0.5 mg/mL nanoparticle 
concentration (Figure 4). 
Figure  4.  Bare  30  nm  nanoparticles  induced  the  highest  level  of  intracellular  ROS 
formation. (A) Selected confocal microscopy ROS images. PAEC were incubated with 
different concentrations of bare and coated nanoparticles for 3 h. Cells were then labeled 
with 10 μM carboxy-H2DCFDA (green), a general ROS indicator. Scale bar = 100 µm;  
(B) Quantification of ROS formation by Image J. # p < 0.05. 
 
2.5. Cell Length and Actin Cytoskeleton 
Cell  length  increased  by  40–60%  when  cells  were  exposed  to  0.5  mg/mL  bare  5  or  30  nm 
nanoparticles.  Actin  cytoskeleton  disruption  was  observed  in  PAEC  loaded  with  0.1,  0.25  and  Int. J. Mol. Sci. 2012, 13  5560 
 
 
0.5 mg/mL bare nanoparticles for both 5 nm and 30 nm after 24 h. Cells with bare nanoparticles were 
more  elongated  compared  to  cells  with  no  nanoparticles  (Figure  5).  Dextran  and  PEG  coated 
nanoparticles had no effect on cell length and did not show actin cytoskeleton disruption. 
Figure 5. Dextran and PEG coated nanoparticles reduced cell elongation and stress fiber 
formation. (A) Selected confocal images of cells labeled for actin. PAEC were incubated 
with  0.5  mg/mL  bare  and  coated  5  and  30  nm  nanoparticles  for  24  h.  Samples  were  
then  fixed  with  paraformaldehyde,  permeabilized  with  Triton  X-100,  and  labeled  with 
rhodamine  phalloidin  (actin,  red)  and  Hoechst  (nuclei,  blue).  Scale  bar  =  20  µm; 
(B) Cell length was quantified by Image J. # p < 0.05. 
 
2.6. 3D Cell Culture 
Nanoparticle toxicity  occurred  at  a lower nanoparticle concentration in  3D vs. 2D cell culture. 
When cells were cultured in alginate scaffolds with either 0.1 mg/mL nanoparticles in the alginate or 
nanoparticles pre-loaded inside cells, bare nanoparticles had the highest degree of cell toxicity for both 
5  and  30  nm  nanoparticles.  Similarly,  cell  toxicity  increased  with  time  for  cells  exposed  to  bare 
nanoparticles. However, dextran and PEG coated nanoparticles did not show significantly reduced cell 
viability at four time points (Figure 6). 
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Figure 6. Dextran and PEG nanoparticle coating improved cell viability in 3D culture.  
(A)  Selected  confocal  images  of  PAEC  viability  in  3D  alginate  constructs  with 
nanoparticles in the alginate, as measured by the Live/Dead assay. Alginate was mixed 
with  0.1  mg/mL  bare  and  coated  nanoparticles  and  cells.  Alginate-nanoparticle-cell 
constructs  were  labeled  using  a  Live/Dead  assay.  Cell  viability  in  3D  constructs  with  
(B) nanoparticles in the alginate and (C) nanoparticles inside cells was measured using an 
Alamar blue assay. 
 
2.7. Discussion 
Iron oxide nanoparticles may be useful across a wide variety of medical applications, including 
magnetic resonance imaging contrast enhancement, immunoassays, and drug delivery [29]. However, 
many aspects of nanoparticle-induced cell toxicity remain unclear. In this study, we showed that both  
5 and 30 nm bare iron oxide nanoparticles decreased  endothelial cell viability. Interestingly, only  
30 nm bare nanoparticles caused a dose dependent increase in ROS formation, whereas both sizes 
induced cell elongation with actin stress fiber formation and eventually cell death. When endothelial 
cells  were  exposed  to  nanoparticles  of  either  size  coated  with  dextran or  PEG,  cell  viability  was 
maintained especially at higher nanoparticle concentrations. Nanoparticle coating effects were similar 
for cells in both 2D and 3D cell culture systems, although lower nanoparticle concentrations were 
cytotoxic in 3D culture. These data suggest that ROS formation contributes to iron oxide nanoparticle 
toxicity for larger particles and can be significantly reduced using biocompatible nanoparticle coatings; Int. J. Mol. Sci. 2012, 13  5562 
 
 
however,  alternative  toxicity  mechanisms  may  similarly  be  reduced  by  nanoparticle  coatings  for 
smaller particles. 
Nanoparticle polysaccharide and polymer coatings can reduce nanoparticle aggregation as well as 
enhance  biocompatibility  [30].  Dextran  and  PEG  coated  nanoparticles  tend  to  form  homogenous 
suspensions  due  to  anisotropic  dipolar  attraction  and  high  surface-to-volume  ratios  [31].  We  still 
observed nanoparticle aggregation in our TEM samples for nanoparticles coated with dextran and PEG, 
although nanoparticles coated with dextran appeared more dispersed in solution. It remains unclear if 
aggregation consistently occurred in solution, during the TEM drying process, or after cell uptake. 
When  we  repeated  our  cytotoxicity  experiments  with  nanoparticles  that  were  coated  with  dextran 
during synthesis, which should be more dispersed than our nanoparticles which were coated after 
synthesis, we observed similar toxicity results. However, nanoparticle aggregation can be decreased by 
controlling  coating  properties,  for  example  by  raising  the  weight  ratio  of  dextran  to  iron  oxide 
nanoparticles [31]. 
TEM images of cells exposed to 5 and 30 nm nanoparticles show nanoparticles clustered in large 
vacuoles, which may have formed by merging smaller vacuoles. No nanoparticles were found in cell 
nuclei, even though the 5 nm particles are smaller than the nuclear pore opening (~ 9 nm). This may be 
due to nanoparticle clustering or rapid nanoparticle isolation in vacuoles. Nanoparticle cellular uptake 
can be affected by many factors, including size, shape, surface charge and functional groups [32].  
In our experiments, intracellular nanoparticles increased with nanoparticle medium concentration for 
all sizes and coatings. However, with the exception of 5 nm dextran coated nanoparticles, the 30 nm 
nanoparticles  showed  higher  internalization  at  3  h  than  the  5  nm  nanoparticles.  Previous  studies 
similarly demonstrated that under the same medium concentration, larger nanoparticles led to higher 
cell internalization when compared with smaller nanoparticles. These larger particles, however, had a 
slower uptake rate [33]. Interestingly, 5 nm dextran coated nanoparticles had the largest cell uptake at 
each concentration. This may be because dextran decreased nanoparticle aggregation, which led to 
faster uptake. However, no significant changes were observed for cell nanoparticle uptake at later time 
points, suggesting that the majority of uptake occurred within the first three hours. Additional studies 
are needed to confirm if 5 nm dextran coated nanoparticles were taken up via a different mechanism 
than the other nanoparticles. 
The  most  likely  mechanism  for  iron  oxide  nanoparticle  cytotoxicity  in  the  literature  is  ROS 
formation [15,34]. In vivo, most ROS are formed as by-products of mitochondrial electron transport or 
via NADPH oxidase, xanthine oxidase, and nitric oxide synthase [35–37]. Superoxide (O2
−) is formed 
by one electron reduction of O2, and further reduction of oxygen (catalyzed by superoxide dismutase) 
leads to hydrogen peroxide (H2O2) formation. Hydrogen peroxide can either be converted to inert 
water and oxygen by catalase, or it can be converted to the highly reactive and damaging hydroxyl 
radical (OH· ) in the presence of metal ions through the Fenton reaction [35]. Throughout the cell, 
antioxidant enzymes such as glutathione (GSH) maintain the cell in a state of low oxidative stress.  
For  iron  oxide  nanoparticle-induced  ROS,  the  initial  reactive  species  are  likely  formed  through  
NADPH-oxidase activation or stabilization during nanoparticle endocytosis. Superoxide and hydrogen 
peroxide are then converted to the more damaging hydroxyl radicals through reactions with the iron. 
The large ROS load may overwhelm the cell’s protective antioxidants [38], and nanoparticle-induced 
ROS will attack lipids, polysaccharides, proteins and DNA, causing cell injury and cell death [15]. Int. J. Mol. Sci. 2012, 13  5563 
 
 
Our data show that for 30 nm nanoparticles, both dextran and PEG coating reduce ROS formation 
and cell toxicity. Dextran and PEG coating block ROS interaction with iron oxide nanoparticles, which 
may prevent the Fenton reaction from occurring and allow the cell’s antioxidant defense to neutralize 
ROS before they become dangerous hydroxyl radicals. Our data further show that 5 nm bare or coated 
nanoparticles do not induce significant ROS formation. This is contrary to our expectations that since 
nanoparticles with a smaller size have a larger surface area/volume ratio, there would be more surface 
interaction of H2O2 with iron, leading to more OH· formation [34]. These small nanoparticles may not 
induce  the  initial  ROS  formation  via  NADPH  oxidase  during  endocytosis,  or  they  may  produce 
reactive OH·  so quickly that by 3 h the ROS levels are already decreasing. In our previous work,  
we showed that ROS levels increased up to 3 h and remained constant, but those experiments were 
performed  with  20–40  nm  nanoparticles.  Additional  investigation  is  needed  to  determine  the 
relationship between 5 nm nanoparticles and ROS. If these small nanoparticles do not cause ROS 
production,  then  the  bare  nanoparticles  likely  induce  a  different  cell  toxicity  mechanism  that  is 
prevented by both dextran and PEG coating.  
The cytoskeleton is a dynamic network consisting of actin polymers, microtubules, and associated 
proteins [39]. Actin in particular plays an important role in cell shape, adhesion, and motility [40,41]. 
Increasing evidence shows that the actin cytoskeleton is essential to endocytotic processes, including 
pseudopod extension, phagocytotic engulfment, and cell surface remodeling for vesicle formation and 
movement  [42].  In  our  experiments,  cells  exposed  to  higher  concentrations  (0.5  mg/mL)  of  bare 
nanoparticles  showed  significant  cell  elongation  and  actin  cytoskeleton  disruption.  While  these 
elongated cells have not yet initiated a cell death pathway, since dying cells would retract and round up, 
they  exhibit  a  significantly  stressed  morphology.  This  could  have  been  a  result  of  iron  oxide 
nanoparticle-induced ROS formation, which alters the cytoskeleton and increases cell permeability and 
microtubule  remodeling  [43].  These  processes  can  redirect  actin  cytoskeleton  polymerization  and 
contraction [44]. These cells may recover from the nanoparticle-induced oxidative stress, or they may 
later progress down a cell death pathway. 
The  majority  of  nanotoxicity  studies  have  been  performed  in  2D  cell  culture.  We  investigated 
whether nanoparticles would show altered toxicity when cells were suspended in a 3D gel. A sodium 
alginate polymer was used because it is nontoxic, biocompatible, and well characterized by our lab and 
others. Alginate forms a gel in the presence of calcium, and since cells do not specifically attach to 
alginate, they do not proliferate in culture which allows isolation of toxicity effects [45]. Similar to 2D 
culture results, cells incubated with bare nanoparticles had the lowest viability after 72 h, while dextran 
and  PEG  coated  nanoparticles  maintained  cell  viability  over  time.  However,  nanoparticles  were  
more toxic at lower concentration in 3D culture. In 2D culture, bare nanoparticles showed significant 
cytotoxicity at 0.5 mg/mL, while in 3D culture bare nanoparticles were cytotoxic at 0.1 mg/mL. This 
may be due to increased contact area between nanoparticles and cells in 3D culture [46]. 
Our experiments showed that polysaccharide and polymer coatings reduce nanoparticle cytotoxicity 
independent  of  nanoparticle  size;  however  our  research  is  not  without  limitations.  While  we 
extensively  sonicated  our  nanoparticles  at  each  experimental  stage,  and  attempted  to  select 
monodispersed  samples,  bare  nanoparticle  aggregation  made  it  difficult  to  evenly  coat  individual 
nanoparticles  and  may  obscure  subtle  size-specific  nanoparticle  effects.  However  we  did  observe 
single nanoparticles in TEM images of nanoparticles alone and nanoparticles inside cells. We further Int. J. Mol. Sci. 2012, 13  5564 
 
 
observed similar cytotoxicity results when experiments were repeated with nanoparticles that were 
synthesized and coated simultaneously (and therefore more dispersed).Our studies were performed  
in vitro, independent of many in vivo conditions including plasma proteins and shear stress from blood 
flow. Future work will include more detailed in vitro experimentation as well as animal studies to 
understand potentially different in vivo toxicity mechanisms. While we believe that nanoparticles are 
taken up by cells through endocytosis, we do not know the effect of different endocytotic mechanisms 
on ROS formation or cell toxicity. Moreover, we used general ROS indicators and inhibitors, and 
therefore did not determine the type of ROS responsible. More specific indicators and inhibiters will 
be used in the future. 
Many  papers  have  recently  been  published  regarding  iron  oxide  nanoparticle  cytotoxicity  in 
different cell systems and with different nanoparticle sizes and coatings. For example, both dextran 
and lipid coatings have been shown to decrease iron oxide nanoparticle cytotoxicity in endothelial cells, 
and very low iron oxide nanoparticle concentrations (that do not induce oxidative stress and toxic 
effects) may negatively impact DNA stability [47–50]. Since each paper differs in method and scope, 
direct comparisons and generalizations are difficult. Yet each study contributes to our understanding of 
cellular nanotoxicity mechanisms and expands our repertoire of nanoparticle modifications that limit 
cytotoxic  effects.  Our  research  in  particular  highlights  that  both  dextran  and  PEG  coatings  can 
decrease  ROS-induced  nanoparticle  toxicity,  toxicity  mechanisms  may  differ  depending  on 
nanoparticle size, and cytotoxicity may increase for cells in 3D culture. 
3. Experimental Section  
3.1. Cell Culture  
Porcine aortic endothelial  cells  (PAEC) were isolated from  porcine aortae and cultured in  low 
glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum and 
1% penicillin-streptomycin. Cells (passage 5 to 8) were maintained in a 37 ° C, 5% CO2 incubator, and 
medium was changed every two days. For 2D cell culture, PAEC were seeded in a 24-well plate at 
200,000 cells/well and cultured for two days. One milliliter nanoparticle solution for each coating and 
concentration was then added to cells for 3–24 h. For 3D cell culture, sodium alginate (1% w/v, FMC 
BioPolymer, Philadelphia, PA, USA) was used as the scaffold material. 0.1 mg/mL 5 or 30 nm bare, 
dextran, or PEG coated nanoparticles were either mixed into the alginate solution at the same time as 
cells  (1.5  ×   10
5  cells/mL),  or  nanoparticles  were  incubated  with  cells  for  24  h  after  which  the 
trypsinized cells with internalized nanoparticles were mixed in the alginate solution. 0.3 g alginate was 
then  deposited  into  a  6-well  plate  and  incubated  with  5%  calcium  chloride  (CaCl2)  as  the  ionic  
cross-linking solution for 5 min, after which supplemented medium was added and samples were 
stored in the incubator. Medium was changed every 2 days to maintain cell viability. 
3.2. Nanoparticle Coating  
Five and thirty nanometer diameter bare iron oxide nanoparticles were purchased from NN-Labs 
(Fayetteville, AR, USA). For dextran coated nanoparticles, 10 mg dextran (MW 6000, Sigma, St. 
Louis, MO, USA) was added to 10 mg iron oxide nanoparticles in 20 mL 0.5 M NaOH and sonicated Int. J. Mol. Sci. 2012, 13  5565 
 
 
with a Sonicator 3000 (Qsonica, Newton, CT, USA) for 0.5 to 1.5 h. Coated nanoparticles were then 
dialyzed using a 12,000–14,000 MW Spectra/Por Dialysis membrane (Spectrum Laboratories, Rancho 
Dominguez, CA, USA) for 24 h in 1.5 L distilled water to remove excess dextran [51]. For PEG 
coating, iron oxide nanoparticles were washed with ethanol and dried in an Isotemp oven (Fisher 
Scientific, Houston, TX) at 100 ° C for 30 min. Ten milligram iron oxide nanoparticles were mixed 
with 5 mL of 3 mM methoxy-PEG-silane (MW 5000, Laysan BioInc, Arab, AL, USA) and sonicated 
for 1 h [52]. The mixture was washed thoroughly with ethanol, and centrifuged for 5 min at 5000 rpm. 
The supernatant was then removed and nanoparticles were resuspended in cell culture medium. 
3.3. Nanoparticle Coating and Cell Uptake by Transmission Electron Microscopy (TEM) 
Dextran and PEG coatings were verified by TEM. Nanoparticle solutions were diluted in distilled 
water, and a single drop of nanoparticle solution was added to a copper TEM grid (Pacific Grid-Tech, 
San Francisco, CA, USA). After each sample was dried at room temperature for 24 h, nanoparticles 
were  imaged  with  a  JEOL  JEM100CX  TEM  at  100  kV.  To  determine  cell  nanoparticle  uptake, 
increasing nanoparticle concentrations were added to confluent PAEC (2 ×  10
5 cells/mL) in a 24 well 
plate  for  3  h.  Samples  were  washed  with  phosphate  buffered  saline  (PBS),  fixed  with  4% 
paraformaldehyde and 2.5% glutaraldehyde for 15 min, and cells were then gently scraped from the 
dish and kept in fixative for another 2 h on ice. Cells were then pelleted and washed with 0.1 M 
sodium  cacodylate  buffer.  The  cell  pellets  were  mixed  with  warmed  3%  agarose  liquid,  and 
subsequently the cooled agarose gel pellets were sliced into 1 mm thick bricks and post fixed with 2% 
osmium  tetroxide  and  0.5%  uranyl  acetate.  Agarose  bricks  were  dehydrated  with  graded  acetone, 
embedded in Epon, polymerized in a 60 ° C oven for 2 days, and cut into ultrathin (100 nm) sections 
for TEM. 
Cell nanoparticle uptake was quantified by dissolving cells and their intracellular nanoparticles and 
measuring  iron  absorbance.  Cells  incubated  with  iron  oxide  nanoparticles  were  trypsinized,  and  
200 µL cell solution was incubated with 200 µL of 1 M NaOH for 30 min at 90 ° C. Five hundred 
microliter of 1 M HCl was then added for 2–3 h to completely dissolve the nanoparticles. Two hundred 
microliter cell lysate was transferred to 96-well-plate, and absorbance (335 nm) was measured with 
GENios microplate reader.  
3.4. Cell Viability 
Cell viability was assessed via a Live/Dead assay (Invitrogen, Grand Island, NY, USA). In the 
presence of intracellular esterases in live cells, nonfluorescent calcein AM is converted to fluorescent 
calcein  (green).  In  dead  cells,  ethidium  homodimer-1  (EthD-1)  enters  through  damaged  cell 
membranes and fluoresces when it binds to nucleic acids (red). Confluent PAEC in 24 well plates were 
incubated with increasing concentrations of bare and coated 5 and 30 nm nanoparticles for 24 h. Two 
micromole  per  liter  calcein  AM  and  4  μM  EthD-1  were  added  to  each  well  for  30  min,  after  
which  cells  were  imaged  in  an  Olympus  IX81  inverted  fluorescent  microscope.  For  3D  samples,  
alginate-nanoparticle-cell constructs were incubated with 500 µL of Live/Dead solution for 30 min and 
then placed on a coverslip just prior to imaging with an Olympus IX81 confocal microscope. A depth 
of 250 µm was scanned in the gel for 3D Live/Dead images. Int. J. Mol. Sci. 2012, 13  5566 
 
 
An Alamar blue assay, which measures cell mitochondrial metabolic activity, was used to confirm 
cell viability in 3D samples [53]. In this assay, the tetrazolium-based dye resazurin is non-fluorescent 
blue until it is reduced in mitochondria to fluorescent red. Alginate-nanoparticle-cell samples were 
incubated with 2 mL medium with 200 μL Alamar blue (AbD Serotec, Raleigh, NC, USA). After  
4 h, 400 µL medium from each sample was measured for fluorescence intensity using a GENios 
microplate reader (excitation/emission: 535/590 nm) [46]. 
3.5. Reactive Oxygen Species (ROS) 
ROS in live cells were detected with the Image-iT Green Reactive Oxygen Species kit (Invitrogen), 
which  uses  5-(and-6)-carboxy-2',7'-dichlorodihydrofluorescein  diacetate  (carboxy-H2DCFDA)  as  a 
general ROS fluorogenic indicator. Tert-butyl hydroperoxide (tBHP) was the positive control, and 
Hoechst 33342 was used to label cell nuclei. Confluent PAEC in 24 well glass bottom dishes were 
incubated with different concentrations of bare and coated 5 and 30 nm nanoparticles for 3 h. Cells 
were labeled with 10 μM carboxy-H2DCFDA and 1.0 mM Hoescht according to the manufacturer’s 
protocol. Samples were then imaged in an Olympus IX81 confocal microscope (excitation/emission 
495/529 nm and 350/461 nm for carboxy-H2DCFDA and Hoechst respectively).  
3.6. Actin Cytoskeleton  
The actin cytoskeleton was labeled to assess changes in cell shape with nanoparticle exposure. 
PAEC were cultured in 24 well plates for 24 h, after which bare and coated 5 and 30 nm iron oxide 
nanoparticles  were  added  for  another  24  h.  Samples  were  then  fixed  with  4%  paraformaldehyde, 
permeabilized with 1% v/v Triton X-100, and incubated with rhodamine phalloidin (1 unit/well, actin) 
in 1% bovine serum albumin (BSA, Sigma) followed by Hoechst (1 μg/mL, nuclei). Samples were 
imaged in by confocal microscopy (excitation/emission: 540/565 for rhodamine phallodin). Cell length 
was measured with Image-J by selecting the distance between the two opposing end points of one cell. 
3.7. Statistical Analysis 
Data are graphed as mean ±  standard deviation. Statistical analyses were performed with Matlab 
and  Excel.  Comparisons  between  two  groups  were  analyzed  using  Student’s  t-test  with  statistical 
significance  at  p  <  0.05  (#)  or  p  <  0.01  (*).  Experiments  were  performed  in  triplicate,  and  each 
experiment was repeated at least 3 times.  
4. Conclusions  
While iron oxide nanoparticles for in vivo applications are coated for safety, these coatings will 
likely degrade in the body or in the environment. It is critical to understand how bare nanoparticles 
interact  with  cells  to  determine  the  effect  of  those  nanoparticles  that  lose  their  coating  either 
extracellularly  or  intracellularly  [8].  We  now  show  that  both  dextran  and  PEG  coating  decrease 
nanoparticle cytotoxicity, but that cytotoxicity mechanisms may vary for different sized nanoparticles. 
In addition, since nanoparticles were more toxic in 3D culture, these types of in vitro systems should 
be considered in future cytotoxicity studies.  Int. J. Mol. Sci. 2012, 13  5567 
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